Extended Spectrum Beta Lactamase:  A Refresher

PIDAC recommendations regarding the response to Extended Spectrum Beta Lactamase (ESBL) producing organisms are outlined in Annex A of PIDAC’s Routine Practices and Additional Precautions Best Practice document.  This session will provide an overview of the recommendations.  In addition, answers to common infection prevention and control questions received by the Regional Infection Control Networks (RICNs) will be discussed.  The session will be of benefit to those health care facilities that may not have a great deal of experience with patients or residents colonized with an ESBL.  A question and answer session following the presentation will invite further dialogue on the appropriate response to ESBLs in different settings and circumstances.

Dr. Vearncombe is a medical microbiologist and medical director of infection prevention and control at Sunnybrook Health Sciences Centre.  She is an associate professor in the department of laboratory medicine and pathobiology at the University of Toronto, chair of the OHA/OMA Joint Committee for Development of Communicable Disease Surveillance Protocols for Ontario Hospitals, chair of the Expert Panel on Infection Control for the faculty of medicine at the University of Toronto, a member of the Steering Committee on Infection Control Guidelines of Health Canada, chair of the Health Canada working group on Infection Prevention and Control and Occupational Health Guidelines for Pandemic Influenza and medical coordinator of the RICNs.

To register for this event, please go to: http://esbl.eventbrite.com/